Xopenex
Product Images NDC 17478-172

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Xopenex (NDC 17478-172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Xop07 0005 01

Xop07 0005 01
FDA Label Image

Xop07 0005 02

Xop07 0005 02
FDA Label Image

Xop07 0005 03

Xop07 0005 03
FDA Label Image

Xop07 0005 04

Xop07 0005 04
FDA Label Image

Xop07 0005 05

Xop07 0005 05
FDA Label Image

Xop07 0005 06

Xop07 0005 06
The text states "Shaded area indicates twist-off tab portion of vial." It may be a label or instruction on a vial indicating where to twist to open it.*
FDA Label Image

Xop07 0005 07

Xop07 0005 07
FDA Label Image

Xop07 0005 08

Xop07 0005 08
FDA Label Image

Xop07 0005 09

Xop07 0005 09
FDA Label Image

Xop07 0005 10

Xop07 0005 10
FDA Label Image

Xop07 0005 11

Xop07 0005 11
FDA Label Image

Xop07 0005 12

Xop07 0005 12
FDA Label Image

Xop07 0005 13

Xop07 0005 13
FDA Label Image

Xop07 0005 14

Xop07 0005 14
FDA Label Image

Xop07 0005 15

Xop07 0005 15
This is a pharmaceutical product containing levalbuterol hydrochloride used for inhalation. The medication is provided in unit-dose vials, and each vial contains 0.31 mg of the medication. This inhalation solution should be used as directed by a physician and should not be used beyond the recommended dosage. The medication must be protected from light and stored at a controlled room temperature of 20 to 25°C (68° to 77°F). The individual vials should be used within one week of being removed from the protective foil pouch. Once the foil pouch is opened, the unit-dose vials should be used within two weeks.*
FDA Label Image

Xop07 0005 16

Xop07 0005 16
FDA Label Image

Xop07 0005 17

Xop07 0005 17
This is a medical product information leaflet for AKN1024-801R00 containing the NDC code, description of potency, storage instructions, and directions for use. It is a unit-dose vial used to treat bronchospasm and is to be stored in a foil pouch at a controlled room temperature between 20° to 25°C. The pharmacist must detach the patient instructions for use before dispensing, and it is not recommended to exceed the recommended dosage. The solution in the vials should be colourless, and the vials should be discarded if not used within two weeks after opening the foil pouch.*
FDA Label Image

Xop07 0005 18

Xop07 0005 18
FDA Label Image

Xop07 0005 19

Xop07 0005 19
This is a product description for a medication called Xopenex (levalbuterol HCl) Inhalation Solution. Each unit dose vial contains 1.25 mg of levalbuterol in an aqueous solution. The solution is free of preservatives and should be used as directed by a physician. The vials should be stored in the protective foil pouch and used within two weeks of opening. The medication should be discarded if the solution is not colorless. The product is distributed by Akon, Inc. for Oak Pharmaceuticals Inc.*
FDA Label Image

Xop07 0005 20

Xop07 0005 20

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.